Recent Posts

1. 

   Sotyktu floundering

   What is the whisper number for Sotyktu? How much this quarter will be clinical buys? Has the drug broken the 5% marketshare barrier?

   Bristol-Myers Squibb

   anonymous

   Apr 24, 2024 at 10:41 AM

2. 

   karuna deal

   Amazing how this troll keeps trying to flip the script from his own post. Actually no insulting here so no need to get so defensive. You posted about these aspirations and ambitions……. Which is quite confusing and rather comical with all the hate...

   Bristol-Myers Squibb

   anonymous

   Apr 24, 2024 at 10:39 AM

3. 

   JH "a proven, inspiring leader"

   def a dumbass

   Regeneron

   anonymous

   Apr 24, 2024 at 10:37 AM

4. 

   Has this place changed at all??

   Nothing has changed with this organization, pay is low, car allowance is low. OON bills.

   Medical Diagnostic Laboratories (MDL)

   anonymous

   Apr 24, 2024 at 10:28 AM

5. 

   Bobby Smithson

   Bobby was forced to be the CCO for about 6-10 months prior to his retirement.

   CPL

   anonymous

   Apr 24, 2024 at 10:25 AM

6. 

   About 3.6 mln Medicare beneficiaries could be eligible for Wegovy coverage, study shows

   via About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for coverage of Novo Nordisk's (NOVOb.CO) weight-loss drug Wegovy, a study published by Kaiser Family Foundation...

   Pharma/Biotech Companies - In the News

   cafead

   Apr 24, 2024 at 10:22 AM

7. 

   Biogen cost cuts drive profit beat, Alzheimer's drug sales jump

   via Biogen (BIIB.O) beat market estimates for first-quarter profit on Wednesday as a series of cost-cutting measures helped offset the impact of fierce competition for its older drugs, sending its shares up nearly 7% before the bell. article source

   Pharma/Biotech Companies - In the News

   cafead

   Apr 24, 2024 at 10:22 AM

8. + Show More